NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. 

Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes.

NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-license them to the world.   From the world to Japan/Asia, NSP in-license promising drug candidates to the Japanese/Asian Markets.

In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies.

NSP aims to be an indispensable entity in the healthcare industry in line with the guidelines for action “Challenge”, “Speed”, and “Investigation”. 


Pharmaceutical

Life Sciences

NS Pharma, Inc.

Yoshihiko Makita

Manabu Beppu

Koji Kimura

Tatsuaki Morokata

Takeshi Seita

Leslie Magnus

Gardner Gendron

The Sales and Marketing team at NS Pharma, Inc. is responsible for driving the company’s commercial strategy to effectively promote and distribute innovative pharmaceuticals. This team collaborates with global partners to identify market opportunities, create impactful marketing campaigns, and enhance sales performance across various channels. They aim to bridge the gap between Japan/Asia and the global market, ensuring NSP's drug candidates reach the patients who need them most.

Sales and Marketing

Patient Access and Market Engagement

Clinical Research and Regulatory Affairs

Leadership Team

Sales and Marketing

About

Team members

Other teams at NS Pharma, Inc.

Patient Access and Market Engagement

Clinical Research and Regulatory Affairs

Leadership Team